Pembrolizumab - National Cancer Institute
Pembrolizumab is used in the treatment of non-small cell lung cancer, head and neck cancer, melanoma and cervical cancer.
Pembrolizumab - Wikipedia
May Treat: Non-small cell lung cancer · Head and neck cancer · Melanoma · Cervical cancer
Pembrolizumab - LiverTox - NCBI Bookshelf
Brand Names: Keytruda
Explore Pembrolizumab With Images
Drug Class: Programmed Cell Death 1 (PD-1) Checkpoint Inhibitors (Monoclonal antibody (mAb))
Pembrolizumab - PubMed
Pregnancy: CONSULT YOUR DOCTOR - Pembrolizumab may be unsafe to use during pregnancy. However, the benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Pembrolizumab (Keytruda) | Cancer Information | Cancer …
Lactation: CONSULT YOUR DOCTOR - Pembrolizumab is probably unsafe to use during lactation.
Pembrolizumab - An Overview | ScienceDirect Topics
Alcohol: CONSULT YOUR DOCTOR - Interaction with alcohol is not known. Please consult your doctor.
Pembrolizumab (Keytruda) - Drug Information | Chemocare
May Treat: Non-small cell lung cancer · Head and neck cancer · Melanoma · Cervical cancer